These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 32849532

  • 1. Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus.
    Liu L, Takeda K, Akkoyunlu M.
    Front Immunol; 2020; 11():1569. PubMed ID: 32849532
    [Abstract] [Full Text] [Related]

  • 2. Circulating CD138 enhances disease progression by augmenting autoreactive antibody production in a mouse model of systemic lupus erythematosus.
    Liu L, Akkoyunlu M.
    J Biol Chem; 2021 Sep; 297(3):101053. PubMed ID: 34364875
    [Abstract] [Full Text] [Related]

  • 3. Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development.
    Wang M, Chen H, Qiu J, Yang HX, Zhang CY, Fei YY, Zhao LD, Zhou JX, Wang L, Wu QJ, Zhou YZ, Zhang W, Zhang FC, Zhang X, Lipsky PE.
    J Autoimmun; 2020 May; 109():102440. PubMed ID: 32201226
    [Abstract] [Full Text] [Related]

  • 4. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J, Niu X, Liu H, Zhang M, Chen M, Deng S.
    Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
    [Abstract] [Full Text] [Related]

  • 5. Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism.
    Richard EM, Thiyagarajan T, Bunni MA, Basher F, Roddy PO, Siskind LJ, Nietert PJ, Nowling TK.
    PLoS One; 2013 Dec; 8(9):e75175. PubMed ID: 24040398
    [Abstract] [Full Text] [Related]

  • 6. CD138 promotes the accumulation and activation of autoreactive T cells in autoimmune MRL/lpr mice.
    Xie T, Liu X, Li P.
    Exp Ther Med; 2023 Dec; 26(6):568. PubMed ID: 37954119
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice.
    Rankin AL, Guay H, Herber D, Bertino SA, Duzanski TA, Carrier Y, Keegan S, Senices M, Stedman N, Ryan M, Bloom L, Medley Q, Collins M, Nickerson-Nutter C, Craft J, Young D, Dunussi-Joannopoulos K.
    J Immunol; 2012 Feb 15; 188(4):1656-67. PubMed ID: 22231702
    [Abstract] [Full Text] [Related]

  • 9. Glucocorticoid prevents CD138 expression in T cells of autoimmune MRL/lpr mice.
    Xie T, Liu H, Li P.
    Mol Med Rep; 2022 Jun 15; 25(6):. PubMed ID: 35514318
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice.
    Suh CH, Freed JH, Cohen PL.
    J Immunol; 2003 Feb 15; 170(4):2229-35. PubMed ID: 12574397
    [Abstract] [Full Text] [Related]

  • 12. Anti-ANX A1 Antibody Therapy in MRL/lpr Murine Model of Systemic Lupus Erythematosus.
    Bradyanova S, Mihaylova N, Chipinski P, Manassiev Y, Herbáth M, Kyurkchiev D, Prechl J, Tchorbanov AI.
    Arch Immunol Ther Exp (Warsz); 2021 Jul 28; 69(1):19. PubMed ID: 34322760
    [Abstract] [Full Text] [Related]

  • 13. Activation of autoreactive T cells that help nucleobindin-injected mice produce anti-DNA antibodies.
    Kubota T, Watanabe N, Kaneko T, Satake F, Miura K, Kurosawa Y, Miyasaka N, Kanai Y.
    Immunol Lett; 2001 Jan 01; 75(2):111-5. PubMed ID: 11137134
    [Abstract] [Full Text] [Related]

  • 14. Calcium signaling in systemic lupus erythematosus T cells: a treatment target.
    Kyttaris VC, Zhang Z, Kampagianni O, Tsokos GC.
    Arthritis Rheum; 2011 Jul 01; 63(7):2058-66. PubMed ID: 21437870
    [Abstract] [Full Text] [Related]

  • 15. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr 01; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

  • 16. Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice.
    Chesnutt MS, Finck BK, Killeen N, Connolly MK, Goodman H, Wofsy D.
    Clin Immunol Immunopathol; 1998 Apr 01; 87(1):23-32. PubMed ID: 9576007
    [Abstract] [Full Text] [Related]

  • 17. The T Cell Receptor Repertoire in Neuropsychiatric Systemic Lupus Erythematosus.
    Moore E, Huang MW, Jain S, Chalmers SA, Macian F, Putterman C.
    Front Immunol; 2020 Apr 01; 11():1476. PubMed ID: 32765512
    [Abstract] [Full Text] [Related]

  • 18. Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent.
    Keller EJ, Dvorina N, Jørgensen TN.
    Int J Mol Sci; 2022 Jan 14; 23(2):. PubMed ID: 35055071
    [Abstract] [Full Text] [Related]

  • 19. Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus.
    Park MJ, Baek JA, Choi JW, Jang SG, Kim DS, Park SH, Cho ML, Kwok SK.
    Front Immunol; 2021 Jan 14; 12():606024. PubMed ID: 33986739
    [Abstract] [Full Text] [Related]

  • 20. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice.
    Fujita Y, Fujii T, Mimori T, Sato T, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Kawanami T, Tanaka M, Masaki Y, Fukushima T, Okazaki T, Umehara H.
    J Immunol; 2014 Feb 01; 192(3):979-84. PubMed ID: 24391210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.